Efficiency analysis of repeated low-level red-light as an alternative treatment therapy for children myopia control
This retrospective cohort study of 70 children and adolescents demonstrates that repeated low-level red-light (RLRL) therapy significantly slows axial length growth and myopia progression over three years compared to single-focal glasses, with a high effective rate and no serious ocular complications.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
In the crowded landscape of childhood vision, nearsightedness has become a pervasive challenge, particularly in parts of the world where it affects a vast number of young people. When a child is nearsighted, their eyeball grows slightly too long, causing light to focus in front of the retina rather than directly on it, which blurs distant objects. As the eye continues to elongate, the condition worsens, and in severe cases, this stretching can lead to serious complications later in life. For decades, the standard approach to managing this progression has involved wearing special glasses or contact lenses, or using eye drops that temporarily relax the eye's focusing muscle. However, these methods are not perfect; some carry side effects, while others require strict daily habits that are difficult for children to maintain. Scientists have long suspected that the health of the tissue layer behind the retina, known as the choroid, plays a critical role in how the eye grows. If this layer becomes thin or lacks proper blood flow, the eye may respond by stretching further. This understanding has led researchers to explore whether a gentle, non-invasive light therapy could help stabilize the eye's growth by improving the health of this underlying tissue.
A team of researchers in Shanghai recently investigated a specific treatment called repeated low-level red-light therapy to see if it could offer a new way to slow down this progression. They gathered a group of thirty-five children and teenagers who were already nearsighted and had them use a desktop device that emits a specific, low-intensity red light. The children used this device twice a day for just three minutes at a time, focusing their eyes on a small spot of light while wearing their regular glasses at all other times. To measure how well this worked, the researchers compared these thirty-five children against another group of thirty-five children of similar age and vision who simply wore standard single-focus glasses without any light therapy. Over the course of three years, both groups were examined every three months to track changes in their vision, the strength of their prescription, and most importantly, the physical length of their eyeballs.
The results of this three-year observation revealed a distinct difference between the two groups. In the children who received the red-light therapy, the length of their eyeballs grew much more slowly than in the children who only wore glasses. While the eyes of the control group continued to lengthen at a steady pace, the eyes of the treatment group showed a unique pattern: they actually shortened slightly during the first six months of therapy before resuming a very slow growth rate. By the end of the third year, the difference in eye growth between the two groups was significant, with the treated eyes remaining noticeably shorter than those in the control group. This physical difference translated into better vision outcomes; the children using the red-light therapy maintained their uncorrected vision much better than the other group, with eighty percent of them showing a positive response to the treatment. The researchers also monitored the children's eyes closely for any signs of damage, such as swelling, infection, or clouding of the lens, and found no such complications in the treatment group.
One notable event occurred during the study when a single child developed a tiny, temporary break in a specific layer of the retina after two years of treatment. This child stopped using the device for a month, and the break healed on its own without any lasting harm. Once the child resumed treatment, no further issues occurred. This isolated incident suggests that while the therapy is generally safe, it requires careful monitoring. The study authors acknowledge that their work has limitations, such as the relatively small number of participants and the fact that it was not a double-blind experiment where neither the doctors nor the patients knew who was receiving the treatment. Despite these constraints, the data strongly suggests that this light therapy can effectively delay the worsening of nearsightedness in children without causing obvious short-term harm. It offers a promising alternative for families seeking to manage their children's vision, potentially reducing the need for more aggressive interventions or the risk of severe vision loss later in life.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.